Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP:phosphocholine cytidylyltransferase

Academic Article


  • Surfactant deficiency contributes to acute lung injury and may result from the elaboration of bioactive lipids such as oxysterols. We observed that the oxysterol 22-hydroxycholesterol (22-HC) in combination with its obligate partner, 9-cis-retinoic acid (9-cis-RA), decreased surfactant phosphatidylcholine (PtdCho) synthesis by increasing phosphorylation of the regulatory enzyme CTP:phosphocholine cytidylyltransferase-α (CCTα). Phosphorylation of CCTα decreased its activity. 22-HC/ 9-cis-RA inhibition of PtdCho synthesis was blocked by PD98059 or dominant-negative ERK (p42 kinase). Overexpression of constitutively active MEK1, the kinase upstream of p42 kinase, increased CCTα phosphorylation. Expression of truncated CCTα mutants lacking proline-directed sites within the C-terminal phosphorylation domain partially blocked oxysterol-mediated inhibition of PtdCho synthesis. Mutagenesis of Ser315 within CCTα was both required and sufficient to confer significant resistance to 22-HC/9-cis-RA inhibition of PtdCho synthesis. A novel putative ERK-docking domain N-terminal to this phosphoacceptor site was mapped within the CCTα membrane-binding domain (residues 287-300). The results are the first demonstration of a physiologically relevant phosphorylation site and docking domain within CCTα that serve as targets for ERKs, resulting in inhibition of surfactant synthesis.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Pubmed Id

  • 11012458
  • Author List

  • Agassandian M; Zhou J; Tephly LA; Ryan AJ; Carter AB; Mallampalli RK
  • Start Page

  • 21577
  • End Page

  • 21587
  • Volume

  • 280
  • Issue

  • 22